First Time Loading...

Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 15.05 AUD -1.25% Market Closed
Updated: May 7, 2024

Wall Street
Price Targets

TLX Price Targets Summary
Telix Pharmaceuticals Ltd

Wall Street analysts forecast TLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLX is 15.59 AUD with a low forecast of 13.66 AUD and a high forecast of 20.27 AUD.

Lowest
Price Target
13.66 AUD
9% Downside
Average
Price Target
15.59 AUD
4% Upside
Highest
Price Target
20.27 AUD
35% Upside
Telix Pharmaceuticals Ltd Competitors:
Price Targets
4893
Noile-Immune Biotech Inc
184% Upside
SPRY
ARS Pharmaceuticals Inc
105% Upside
300406
Beijing Strong Biotechnologies Inc
16% Upside
ARDX
Ardelyx Inc
49% Upside
BIOA B
BioArctic AB
88% Upside
CSL
CSL Ltd
12% Upside
688278
Xiamen Amoytop Biotech Co Ltd
27% Upside
NKTX
Nkarta Inc
177% Upside

Revenue
Forecast

Revenue Estimate
Telix Pharmaceuticals Ltd

For the last 5 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 381%. The projected CAGR for the next 3 years is 26%.

381%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Telix Pharmaceuticals Ltd

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 3 years is 110%.

N/A
Past Growth
110%
Estimated Growth
Estimates Accuracy
29%
Average Beat

Net Income
Forecast

Net Income Estimate
Telix Pharmaceuticals Ltd

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 3 years is 180%.

N/A
Past Growth
180%
Estimated Growth
Estimates Accuracy
10%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLX's stock price target?
Price Target
15.59 AUD

According to Wall Street analysts, the average 1-year price target for TLX is 15.59 AUD with a low forecast of 13.66 AUD and a high forecast of 20.27 AUD.

What is Telix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
26%

For the last 5 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 381%. The projected CAGR for the next 3 years is 26%.

What is Telix Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
110%

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 3 years is 110%.

What is Telix Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
180%

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 3 years is 180%.